DHX Company Co., Ltd. (KOSDAQ:031860)

South Korea flag South Korea · Delayed Price · Currency is KRW
693.00
+102.00 (17.26%)
At close: Apr 3, 2026
Market Cap13.15B -23.0%
Revenue (ttm)14.51B +52.0%
Net Income-33.19B
EPS-1,885.00
Shares Out18.98M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,766,793
Average Volume2,395,026
Open597.00
Previous Close591.00
Day's Range597.00 - 755.00
52-Week Range202.00 - 1,783.00
Beta-0.60
RSI60.48
Earnings DateMar 27, 2026

About DHX Company

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution; and meditech distribution. In addition, the company is involved in manufacture and distribution of computers and peripherals; investment and asset ma... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1979
Employees 23
Stock Exchange KOSDAQ
Ticker Symbol 031860
Full Company Profile

Financial Performance

In 2025, DHX Company's revenue was 14.51 billion, an increase of 52.05% compared to the previous year's 9.54 billion. Losses were -33.19 billion, 88.7% more than in 2024.

Financial Statements